TRUFF (Rhelion Life Sciences) Graham Number: $0.02 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rhelion Life Sciences Graham Number?

Rhelion Life Sciences TRUFF -14.06% Graham Number is $0.02 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 600 Drug Manufacturers companies, Rhelion Life Sciences ranks better than 81.83% on this metric.

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2026-08-18), the stock price of Rhelion Life Sciences is $0.0214. Rhelion Life Sciences's graham number for the quarter that ended in Mar. 2026 was $0.02. Therefore, Rhelion Life Sciences's Price to Graham Number ratio for today is 1.01.

The historical rank and industry rank for Rhelion Life Sciences's Graham Number or its related term are showing as below:

TRUFF' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.83
Current: 0.71

During the past 8 years, the highest Price to Graham Number ratio of Rhelion Life Sciences was 0.83. The lowest was 0.00. And the median was 0.00.

TRUFF's Price-to-Graham-Number is ranked better than
81.83% of 600 companies
in the Drug Manufacturers industry
Industry Median: 1.595 vs TRUFF: 0.71

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


Rhelion Life Sciences  (OTCPK:TRUFF) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

Rhelion Life Sciences's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Mar. 2026 )
=0.0214/0.02
=1.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


Rhelion Life Sciences Graham Number Related Terms


Rhelion Life Sciences Graham Number Historical Data

* Premium members only.

The historical data trend for Rhelion Life Sciences's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhelion Life Sciences Graham Number Chart

Rhelion Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Graham Number
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Rhelion Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Graham Number Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.02 0.02 0.02

TRUFF vs ZTS: Graham Number Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rhelion Life Sciences's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhelion Life Sciences Price-to-Graham-Number vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rhelion Life Sciences's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where Rhelion Life Sciences's Price-to-Graham-Number falls into.



Rhelion Life Sciences Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

Rhelion Life Sciences's Graham Number for the fiscal year that ended in Mar. 2026 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*0.02*-0.005)
=N/A

Rhelion Life Sciences's Graham Number for the quarter that ended in Mar. 2026 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*0.02*0.001)
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Graham Number →
What does a Graham Number of $0.02 mean?
Rhelion Life Sciences (TRUFF) has a Graham Number of $0.02 as of Mar. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Rhelion Life Sciences and its competitors. According to the industry distribution chart, Rhelion Life Sciences ranks #109 out of 600 companies in the Drug Manufacturers industry, placing it in the top 18.2%.
Is Rhelion Life Sciences' Graham Number too high?
Rhelion Life Sciences' current Graham Number is $0.02. The Drug Manufacturers industry median Graham Number is 1.60. Rhelion Life Sciences' value of $0.02 is 98.7% below this industry median. Based on the distribution chart, Rhelion Life Sciences ranks #109 out of 600 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Rhelion Life Sciences' Graham Number compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Rhelion Life Sciences ranks #109 out of 600 companies for Graham Number. This places Rhelion Life Sciences in the top 18% of its industry — outperforming the majority of peers. The industry median Graham Number is 1.60. Rhelion Life Sciences' value of $0.02 is 98.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Drug Manufacturers company?
The median Graham Number among Drug Manufacturers companies is 1.60, based on 600 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhelion Life Sciences's current Graham Number of $0.02 is 98.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Rhelion Life Sciences and its competitors. For the Drug Manufacturers industry, the median Graham Number is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhelion Life Sciences's current Graham Number is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhelion Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Rhelion Life Sciences (TRUFF) is currently considered Fairly Valued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 7% above its estimated fair value. The current Graham Number is $0.02 and 98.7% below the Drug Manufacturers industry median of 1.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Rhelion Life Sciences (TRUFF), the current Graham Number is $0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rhelion Life Sciences Business Description

Other Exchanges 4YX:GermanyTRIP:Canada
Address 1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Red Light Holland Corp is engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands. Its products include Microdosing Kit and Merch. Its revenue is comprised of sales of wholesale truffles, cannabis seeds, and other cannabis products and sales of microdose packs.